Assessment of environmental enteric dysfunction in the SHINE Trial: Methods and challenges

Clinical Infectious Diseases

Volumn 61, Issue , 2015, Pages S726-S732

  Prendergast, Andrew J ^a,b,c   Humphrey, Jean H ^a,c   Mutasa, Kuda ^a   Majo, Florence D ^a   Rukobo, Sandra ^a   Govha, Margaret ^a   Mbuya, Mduduzi N N ^a,c,d   Moulton, Lawrence H ^c   Stoltzfus, Rebecca J ^d  

^a Zvitambo Institute for Maternal and Child Health Research   (Zimbabwe)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d Department of Molecular Biology and Genetics   (United States)

Author keywords

environmental enteric dysfunction; IGF 1; infants; inflammation; stunting

Indexed keywords

ALPHA 1 ANTITRYPSIN; FATTY ACID BINDING PROTEIN 2; FERRITIN; GROWTH HORMONE; HEPCIDIN; MYELOPEROXIDASE; NEOPTERIN; POLIOMYELITIS VACCINE; REGENERATING GENE 1BETA PROTEIN; ROTAVIRUS VACCINE; SOMATOMEDIN BINDING PROTEIN 1; TRANSFERRIN RECEPTOR; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ANEMIA; ARTICLE; BACTERIAL TRANSLOCATION; BLOOD SAMPLING; BLOOD STORAGE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; ENVIRONMENTAL ENTERIC DYSFUNCTION; ENVIRONMENTAL SANITATION; HUMAN; INFANT FEEDING; INFLAMMATION; INTESTINE FLORA; MORBIDITY; PATHOPHYSIOLOGY; POPULATION; PRIORITY JOURNAL; SMALL INTESTINE DISEASE; SOCIAL HYGIENE; STUNTING SYNDROME; TREATMENT RESPONSE; VACCINATION; WATER SUPPLY; CONTROLLED STUDY; EATING; FECES; FEMALE; GROWTH DISORDER; HYGIENE; IMMUNOLOGY; INFANT; INTESTINE; MALE; METHODOLOGY; MICROBIOLOGY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RURAL POPULATION; SANITATION; ZIMBABWE;

ANEMIA; BIOMARKERS; EATING; FECES; FEMALE; GASTROINTESTINAL MICROBIOME; GROWTH DISORDERS; HUMANS; HYGIENE; INFANT; INFLAMMATION; INTESTINES; MALE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; RURAL POPULATION; SANITATION; ZIMBABWE;

EID: 84950323422     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/civ848     Document Type: Article

References (43)

1. The Sanitation Hygiene Infant Nutrition Efficacy (SHINE) Trial Team. The Sanitation Hygiene Infant Nutrition Efficacy (SHINE) trial: Rationale, design and methods. Clin Infect Dis 2015; 61(suppl 7):S685-702.
2. Kelly P, Menzies I, Crane R, et al. Responses of small intestinal architecture and function over time to environmental factors in a tropical population. Am J Trop Med Hyg 2004; 70:412-9.
3. Lindenbaum J, Alam AK, Kent TH. Subclinical small-intestinal disease in East Pakistan. Br Med J 1966; 2:1616-9.
4. Lindenbaum J, Gerson CD, Kent TH. Recovery of small-intestinal structure and function after residence in the tropics. I. Studies in Peace Corps volunteers. Ann Intern Med 1971; 74:218-22.
5. Lindenbaum J, Harmon JW, Gerson CD. Subclinical malabsorption in developing countries. Am J Clin Nutr 1972; 25:1056-61.
6. Prendergast A, Kelly P. Review: Enteropathies in the developing world: Neglected effects on global health. Am J Trop Med Hyg 2012; 86: 756-63.
7. Campbell DI, Elia M, Lunn PG. Growth faltering in rural Gambian infants is associated with impaired small intestinal barrier function, leading to endotoxemia and systemic inflammation. J Nutr 2003; 133: 1332-8.
8. Lunn PG, Northrop-Clewes CA, Downes RM. Intestinal permeability, mucosal injury, and growth faltering in Gambian infants. Lancet 1991; 338:907-10.
9. Keusch GT, Denno DM, Black RE, et al. Environmental enteric dysfunction: Pathogenesis, diagnosis, and clinical consequences. Clin Infect Dis 2014; 59(suppl 4):S207-12.
10. Kosek M, Haque R, Lima A, et al. Fecal markers of intestinal inflammation and permeability associated with the subsequent acquisition of linear growth deficits in infants. Am J Trop Med Hyg 2013; 88:390-6.
11. Prendergast AJ, Rukobo S, Chasekwa B, et al. Stunting is characterized by chronic inflammation in Zimbabwean infants. PLoS One 2014; 9: E86928.
12. Korpe PS, PetriWA Jr. Environmental enteropathy: Critical implications of a poorly understood condition. Trends Mol Med 2012; 18:328-36.
13. Mayer EA, Tillisch K, Gupta A. Gut/brain axis and the microbiota. J Clin Invest 2015; 125:926-38.
14. Prendergast AJ, Humphrey JH. The stunting syndrome in developing countries. Paediatr Int Child Health 2014; 34:250-65.
15. Romero R, Espinoza J, Goncalves LF, Kusanovic JP, Friel L, Hassan S. The role of inflammation and infection in preterm birth. Semin Reprod Med 2007; 25:21-39.
16. Menzies IS, Zuckerman MJ, Nukajam WS, et al. Geography of intestinal permeability and absorption. Gut 1999; 44:483-9.
17. Keusch GT, Rosenberg IH, Denno DM, et al. Implications of acquired environmental enteric dysfunction for growth and stunting in infants and children living in low-and middle-income countries. Food Nutr Bull 2013; 34:357-64.
18. Humphrey JH. Child undernutrition, tropical enteropathy, toilets, and handwashing. Lancet 2009; 374:1032-5.
19. Petri WA, Naylor C, Haque R. Environmental enteropathy and malnutrition: Do we know enough to intervene? BMC Med 2014; 12:187.
20. Denno DM, VanBuskirk K, Nelson ZC, Musser CA, Hay Burgess DC, Tarr PI. Use of the lactulose to mannitol ratio to evaluate childhood environmental enteric dysfunction: A systematic review. Clin Infect Dis 2014; 59(suppl 4):S213-9.
21. Kawanami C, Fukui H, Kinoshita Y, et al. Regenerating gene expression in normal gastric mucosa and indomethacin-induced mucosal lesions of the rat. J Gastroenterol 1997; 32:12-8.
22. Peterson KM, Buss J, Easley R, et al. REG1B as a predictor of childhood stunting in Bangladesh and Peru. Am J Clin Nutr 2013; 97: 1129-33.
23. Campbell DI, Lunn PG, Elia M. Age-related association of small intestinal mucosal enteropathy with nutritional status in rural Gambian children. Br J Nutr 2002; 88:499-505.
24. Campbell DI, McPhail G, Lunn PG, Elia M, Jeffries DJ. Intestinal inflammation measured by fecal neopterin in Gambian children with enteropathy: Association with growth failure, Giardia lamblia, and intestinal permeability. J Pediatr Gastroenterol Nutr 2004; 39:153-7.
25. Goto R, Mascie-Taylor CG, Lunn PG. Impact of intestinal permeability, inflammation status and parasitic infections on infant growth faltering in rural Bangladesh. Br J Nutr 2009; 101:1509-16.
26. Northrop-Clewes CA, Rousham EK, Mascie-Taylor CN, Lunn PG. Anthelmintic treatment of rural Bangladeshi children: Effect on host physiology, growth, and biochemical status. Am J Clin Nutr 2001; 73:53-60.
27. Goto R, Panter-Brick C, Northrop-Clewes CA, Manahdhar R, Tuladhar NR. Poor intestinal permeability in mildly stunted Nepali children: Associations with weaning practices and Giardia lamblia infection. Br J Nutr 2002; 88:141-9.
28. Lima NL, Soares AM, Mota RM, Monteiro HS, Guerrant RL, Lima AA. Wasting and intestinal barrier function in children taking alanyl-glutamine-supplemented enteral formula. J Pediatr Gastroenterol Nutr 2007; 44:365-74.
29. Lostia AM, Lionetto L, Principessa L, et al. A liquid chromatography/mass spectrometry method for the evaluation of intestinal permeability. Clin Biochem 2008; 41:887-92.
30. Laker MF, Bull HJ, Menzies IS. Evaluation of mannitol for use as a probe marker of gastrointestinal permeability in man. Eur J Clin Invest 1982; 12:485-91.
31. Menzies IS, Jenkins AP, Heduan E, Catt SD, Segal MB, Creamer B. The effect of poorly absorbed solute on intestinal absorption. Scand J Gastroenterol 1990; 25:1257-64.
32. Kosek M, Guerrant RL, Kang G, et al. Assessment of environmental enteropathy in the MAL-ED cohort study: Theoretical and analytic framework. Clin Infect Dis 2014; 59(suppl 4):S239-47.
33. Camilleri M, Nadeau A, Lamsam J, et al. Understanding measurements of intestinal permeability in healthy humans with urine lactulose and mannitol excretion. Neurogastroenterol Motil 2010; 22:e15-26.
34. Lieberman JM, Sacchettini J, Marks C, Marks WH. Human intestinal fatty acid binding protein: Report of an assay with studies in normal colunteers and intestinal ischemia. Surgery 1997; 121:335-42.
35. Derikx JPM, Vreugdenhil ACE, Van den Neucker AM, et al. A pilot study on the noninvasive evaluation of intestinal damage in celiac disease using I-FABP and L-FABP. J Clin Gastroenterol 2009; 43:727-33.
36. Mondal D, Minak J, Alam M, et al. Contribution of enteric infection, altered intestinal barrier function, and maternal malnutrition to infant malnutrition in Bangladesh. Clin Infect Dis 2012; 54:185-92.
37. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340:448-54.
38. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: Biological actions. Endocr Rev 1995; 16:3-34.
39. Isaksson OG, Jansson JO, Gause IA. Growth hormone stimulates longitudinal bone growth directly. Science 1982; 216:1237-9.
40. Walters TD, Griffiths AM. Mechanisms of growth impairment in pediatric Crohn's disease. Nat Rev Gastroenterol Hepatol 2009; 6:513-23.
41. George CM, Oldja L, Biswas SK, et al. Fecal markers of environmental enteropathy are associated with animal exposure and caregiver hygiene in Bangladesh. Am J Trop Med Hyg 2015; 93:269-75.
42. MacKinnon DP, Lockwood CM, Hoffman JM, West SG, Sheets V. A comparison of methods to test mediation and other intervening variable effects. Psychol Methods 2002; 7:83-104.
43. Crane RJ, Jones KD, Berkley JA. Environmental enteric dysfunction: An overview. Food Nutr Bull 2015; 36:S76-87.